Antimicrobial Stewardship in the Management of Healthcare-Associated Infections

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 542

Special Issue Editors


E-Mail Website
Guest Editor
College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA
Interests: antimicrobial stewardship; antimicrobial resistance; medical education

E-Mail Website
Guest Editor
Department of Pharmacy, Department of Medicine, Montefiore Medical Center, New York, NY, USA
Interests: antimicrobial stewardship; antimicrobial resistance; antimicrobial utilization/evaluation; antiretroviral prescribing errors

Special Issue Information

Dear Colleagues,

Healthcare-associated infections (HAIs) are recognized as an important global public health and patient safety issue. The World Health Organization estimates that out of every 100 patients in acute-care facilities, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one HAI during their hospital stay. In the United States, about 1 in 31 hospitalized patients has at least one HAI. In preventing HAIs, antimicrobial stewardship programs work vigorously and collaboratively with infection prevention and control in developing top, innovative defense strategies to slow the emergence and spread of antimicrobial resistance.

This Special Issue is focused on antimicrobial stewardship strategies targeting HAIs. We welcome the submission of manuscripts in the form of original research, brief reports, systematic reviews and meta-analyses, reviews, perspectives, opinions, and interesting cases that highlight antimicrobial stewardship efforts in managing HAIs, such as (but not limited to) central line-associated bloodstream infections, catheter-associated urinary tract infections, surgical site infections, hospital-onset C. difficile infections, ventilator-associated pneumonia, and hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections.

Dr. Yuman (Yumi) Lee
Dr. Yi Guo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • healthcare-associated infections
  • HAIs
  • antimicrobial stewardship
  • antimicrobial resistance

Published Papers

This special issue is now open for submission.
Back to TopTop